Free Trial
NASDAQ:POAI

Predictive Oncology (POAI) Stock Price, News & Analysis

Predictive Oncology logo
$0.87 -0.04 (-4.70%)
As of 03:48 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Predictive Oncology Stock (NASDAQ:POAI)

Key Stats

Today's Range
$0.88
$0.91
50-Day Range
$0.73
$0.93
52-Week Range
$0.55
$3.06
Volume
31,772 shs
Average Volume
1.87 million shs
Market Capitalization
$9.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Predictive Oncology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
10th Percentile Overall Score

POAI MarketRank™: 

Predictive Oncology scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Predictive Oncology are expected to grow in the coming year, from ($2.08) to ($0.13) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Predictive Oncology is -0.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Predictive Oncology is -0.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Predictive Oncology's valuation and earnings.
  • Percentage of Shares Shorted

    1.25% of the float of Predictive Oncology has been sold short.
  • Short Interest Ratio / Days to Cover

    Predictive Oncology has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Predictive Oncology has recently increased by 13.82%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Predictive Oncology does not currently pay a dividend.

  • Dividend Growth

    Predictive Oncology does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.25% of the float of Predictive Oncology has been sold short.
  • Short Interest Ratio / Days to Cover

    Predictive Oncology has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Predictive Oncology has recently increased by 13.82%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Predictive Oncology has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Predictive Oncology this week, compared to 1 article on an average week.
  • Search Interest

    4 people have searched for POAI on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Predictive Oncology insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.44% of the stock of Predictive Oncology is held by insiders.

  • Percentage Held by Institutions

    Only 9.04% of the stock of Predictive Oncology is held by institutions.

  • Read more about Predictive Oncology's insider trading history.
Receive POAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Predictive Oncology and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

POAI Stock News Headlines

This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.tc pixel
See More Headlines

POAI Stock Analysis - Frequently Asked Questions

Predictive Oncology's stock was trading at $0.82 at the beginning of the year. Since then, POAI shares have increased by 6.7% and is now trading at $0.8750.

Predictive Oncology Inc. (NASDAQ:POAI) posted its earnings results on Wednesday, August, 13th. The medical instruments supplier reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by $0.13. The medical instruments supplier had revenue of $0 million for the quarter, compared to analyst estimates of $1.50 million. Predictive Oncology had a negative net margin of 587.31% and a negative trailing twelve-month return on equity of 722.01%.

Shares of Predictive Oncology reverse split on Monday, April 24th 2023.The 1-20 reverse split was announced on Monday, April 24th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, April 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of POAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Predictive Oncology investors own include Ford Motor (F), Wells Fargo & Company (WFC), Zomedica (ZOM), JPMorgan Chase & Co. (JPM), Abbott Laboratories (ABT), Bank of America (BAC) and Wayfair (W).

Company Calendar

Last Earnings
8/13/2025
Today
8/29/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:POAI
CIK
1446159
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.66 million
Net Margins
-587.31%
Pretax Margin
-546.76%
Return on Equity
-722.01%
Return on Assets
-167.23%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.32
Quick Ratio
0.31

Sales & Book Value

Annual Sales
$1.62 million
Price / Sales
6.15
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.15) per share
Price / Book
-6.10

Miscellaneous

Outstanding Shares
10,890,000
Free Float
10,518,000
Market Cap
$9.96 million
Optionable
Not Optionable
Beta
1.18

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:POAI) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners